Merck has entered into a business transfer agreement (BTA) with Merck Life Science (MLSPL) for the transfer of the Company's biopharma (BP), performance materials (PM) and life science (LS) businesses to MLSPL and/or its affiliates.
The Company has also entered into an agreement with MLSPL, Merck Specialities (MSPL) and Merck Performance Materials (MPMPL) for the said direct transfer of the BP and PM businesses to MSPL and MPMPL respectively.
MSPL and MPMPL are affiliates of MLSPL, all three entities being subsidiaries of the Company's ultimate holding company, Merck KGaA, Dannstadt, Germany.
Merck is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments. The company operates through two segments - Pharmaceuticals and Chemicals.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |